The rising incidence of cancer worldwide has led to an increasing number of surgeries that involve the removal of lymph nodes ...
Rescuing larvae from missile-damaged lab, Weizmann team finds cells that not only beat back death, but also multiply and spur ...
InvestorsHub on MSN
BioVaxys posts encouraging ovarian cancer data from MVP-S combo trial
BioVaxys Technology Corp. (CSE:BIOV) (USOTC:BVAXF) said it has reported positive early results from its Phase 1B/2 PESCO ...
Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are ...
In a study published in Cell Research, researchers have identified a fibrous-layer resident subpopulation of P-SSCs labeled ...
When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages, our cells work ...
When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...
Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...
Positive interim safety results from the first two dose escalation cohorts, referred to as Cohorts 1 and 2, were reported in 4Q 2024. Today’s update is focused on safety and molecular findings from ...
A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback